Helix BioPharma (HBP) Competitors C$0.93 0.00 (0.00%) As of 06/13/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock HBP vs. BCT, IPA, TH, SCYB, COM, APS, NVH, IGX, PDP, and MDNAShould you be buying Helix BioPharma stock or one of its competitors? The main competitors of Helix BioPharma include BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Theratechnologies (TH), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Aptose Biosciences (APS), Novoheart (NVH), IntelGenx Technologies (IGX), Pediapharm (PDP), and Medicenna Therapeutics (MDNA). These companies are all part of the "biotechnology" industry. Helix BioPharma vs. Its Competitors BriaCell Therapeutics ImmunoPrecise Antibodies Theratechnologies Scythian Biosciences 138267 (COM.TO) Aptose Biosciences Novoheart IntelGenx Technologies Pediapharm Medicenna Therapeutics Helix BioPharma (TSE:HBP) and BriaCell Therapeutics (CVE:BCT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings, analyst recommendations, media sentiment and community ranking. Which has better valuation and earnings, HBP or BCT? BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Helix BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHelix BioPharmaN/AN/A-C$50.55M-C$0.95-0.98BriaCell TherapeuticsN/AN/AN/A-C$0.38-28.19 Does the MarketBeat Community prefer HBP or BCT? Helix BioPharma received 26 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. However, 68.97% of users gave BriaCell Therapeutics an outperform vote while only 63.46% of users gave Helix BioPharma an outperform vote. CompanyUnderperformOutperformHelix BioPharmaOutperform Votes6663.46% Underperform Votes3836.54% BriaCell TherapeuticsOutperform Votes4068.97% Underperform Votes1831.03% Does the media favor HBP or BCT? In the previous week, Helix BioPharma's average media sentiment score of 0.00 equaled BriaCell Therapeutics'average media sentiment score. Company Overall Sentiment Helix BioPharma Neutral BriaCell Therapeutics Neutral Is HBP or BCT more profitable? Helix BioPharma's return on equity of 1,803.57% beat BriaCell Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Helix BioPharmaN/A 1,803.57% -279.98% BriaCell Therapeutics N/A N/A N/A SummaryHelix BioPharma and BriaCell Therapeutics tied by winning 3 of the 6 factors compared between the two stocks. Get Helix BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HBP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HBP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HBP vs. The Competition Export to ExcelMetricHelix BioPharmaBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$49.31MC$126.08MC$5.57BC$6.07BDividend Yield1.50%3.74%5.27%6.72%P/E Ratio-0.983.2526.7836.73Price / SalesN/A4,108.15404.491,028.25Price / Cash11.3213.1938.2583.29Price / Book-6.6835.866.964.19Net Income-C$50.55M-C$91.56MC$3.23BC$301.20M7 Day PerformanceN/A0.31%-1.24%1.24%1 Month Performance-3.12%6.18%8.34%6.31%1 Year Performance287.50%178.38%33.30%29.15% Helix BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HBPHelix BioPharmaN/AC$0.93flatN/AN/AC$49.31MN/A-0.989BCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownTHTheratechnologiesN/AC$3.59-0.3%N/A+98.8%C$114.54MC$52.22M-40.64103SCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/AAPSAptose BiosciencesN/AC$2.33-1.7%N/A-94.2%C$100.33MN/A-0.4631Gap UpNVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423.50K-13.95N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpPDPPediapharmN/AC$0.30+1.7%N/A+0.0%C$66.36MC$11.16M-4.11N/AMDNAMedicenna TherapeuticsN/AC$0.87-4.4%N/A-60.5%C$65.09MC$4.87K-2.4020 Related Companies and Tools Related Companies BriaCell Therapeutics Competitors ImmunoPrecise Antibodies Competitors Theratechnologies Competitors Scythian Biosciences Competitors 138267 (COM.TO) Competitors Aptose Biosciences Competitors Novoheart Competitors IntelGenx Technologies Competitors Pediapharm Competitors Medicenna Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:HBP) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix BioPharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helix BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HBP Stock Free HBP Stock Alerts